In research on many anti-cancer drugs, the MAPK/mTOR/p70S6K and Akt pathways or the PI3k-Akt pathway are involved in the regulation of pAKT expression and contribute to inhibition of tumor growth [75,76,77,78]. This evidence concerns the gene AKT1 and neoplasm.